Every Spin-Off
Abbott Nutrition (name TBA)
AnnouncedMakes infant formula (Similac), adult nutrition drinks (Ensure, Glucerna) and rehydration products (Pedialyte), sold worldwide.
Abbott's nutrition business: infant formula, adult nutrition and rehydration drinks, about $8.5bn of annual sales.
- Status
- Announced
- Expected
- By end of 2027
- Parent
- Abbott Laboratories (ABT)
- Spin-off ticker
- To be announced
- Market
- United States
- Sector
- Consumer staples
Terms
Announced 21 Oct 2026 with third-quarter results: a tax-free distribution of the new nutrition company's shares to Abbott shareholders, to be completed by the end of 2027. Needs regulatory approvals, an effective Form 10 and final board approval. Daniel Salvadori, head of Established Pharmaceuticals and Nutritional Products, is CEO-designate.
Key dates
- Separation announced
- Targeted completion
Source documents
- Press releaseAbbott Q3 2026 results and planned nutrition spin-off (8-K ex. 99.1, 21 Oct 2026)
- PresentationNot yet published
- Form 10 / prospectusNot yet public
- Sourcefool.com, Q3 2026 earnings call transcript
Every Spin-Off research
No report on this situation yet. New reports are published on Substack first.
Receive reports by email